MASI

Health Care Sector Update for 03/25/2024: MASI, ESPR, OCGN, XLV, IBB

Health care stocks were steady premarket Monday as the iShares Biotechnology ETF (IBB) was inactive and the Health Care Select Sector SPDR Fund (XLV) was down a slight 0.1% recently.

Masimo (MASI) activist investor Politan Capital Management said it is nominating two candidates to the health technology company's board. Masimo was up more than 12% pre-bell.

Esperion Therapeutics (ESPR) was over 19% higher after the company said the US Food and Drug Administration approved Nexletol and Nexlizet for expanded use in cardiovascular risk reduction and lowering low-density lipoprotein cholesterol for both primary and secondary prevention patients.

Ocugen (OCGN) was up more than 11% after a federal appeals court upheld a lower-court decision, dismissing allegations of misleading shareholders with its statements about a prospective COVID-19 vaccine and its approvals in the US.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.